POCI Nasdaq Electromedical & Electrotherapeutic Apparatus Financials FY2017βFY2026
Precision Optics Corporation, Inc. had $31.5M of revenue in fiscal 2026, up 65.2% on the year before. Over five years, revenue changed +24.2% a year on average.
Last close Β· Oct 23, 2026
$4.33
2.4%Hi! I read Precision Optics Corporation, Inc.βs latest annual report (fiscal 2026). Here is what stands out:
Good So-so Weak
Are sales growing?
+65.2%
Yes. Sales grew 65.2% last year.
Does it make a profit?
β11.5%
No. It lost money last year.
Does profit turn into cash?
β6.3%
No. It spent more cash than it brought in.
How healthy are the accounts?
5 / 9
Mixed. It passes 5 of 9 health tests.
How is the share priced?
β
No P/E: it made no profit over the last four quarters.
Rules of thumb on reported numbers. A starting point, not a recommendation.
Is it selling more, and how much does it keep?
In plain words: Every quarter, companies publish how much they sold and earned. These are the days Precision Optics Corporation, Inc. did it, and the next one. Share prices often move a lot on those days.
Next results
November 12, 2026
Thursday Β· in 17 days
| Date | Results for | Time | Source |
|---|---|---|---|
| Sep 28, 2026 | Q4 '26 | After the market closes | 8-K β |
| May 13, 2026 | Q3 '26 | After the market closes | 10-Q β |
| Feb 17, 2026 | Q2 '26 | After the market closes | 10-Q β |
| Nov 13, 2025 | Q1 '26 | After the market closes | 10-Q β |
| Sep 29, 2025 | Q4 '25 | After the market closes | 10-K β |
| May 15, 2025 | Q3 '25 | After the market closes | 10-Q β |
| Feb 13, 2025 | Q2 '25 | After the market closes | 10-Q β |
| Nov 14, 2024 | Q1 '25 | After the market closes | 10-Q β |
From SEC filings: the results press release (8-K) or, without one, the quarterly or annual report.
KIRA Β· Precision Optics Corporation, Inc. had $31.5M of revenue in fiscal 2026, up 65.2% on the year before. Over five years, revenue changed +24.2% a year on average. Its operating margin was β11.1%, up 18.0Β pts: of every 100 in sales, about β11 is left after running the business.
In plain words: Revenue is all the money customers paid. The margins show how many cents of each dollar of sales are left over at each step: after making the product (gross), after running the business (operating) and after everything, tax included (net).
Revenue
Revenue
Margins, % of revenue
Margins, % of revenue
KIRA Β· Precision Optics Corporation, Inc. lost $3.6M in fiscal 2026.
Loss periods are shown in red.
In plain words: Net income is the profit left after every cost and tax. Earnings per share (EPS) splits that profit across every share, so it shows what one share earned.
Net income
Net income
Diluted EPS
Diluted EPS
How much cash comes in, and where does it go?
KIRA Β· Free cash flow was β$2.0M in fiscal 2026, β6.3% of revenue.
Cash from operations minus capital spending.
In plain words: Profit on paper is not the same as cash in the bank. Free cash flow is the cash left after paying to run and maintain the business: the money it can hand back to shareholders, save or invest.
Free cash flow
Free cash flow
Cash from operations vs capital spending
Cash from operations vs capital spending
In plain words: Companies hand cash back in two ways: dividends (cash paid to shareholders) and buybacks (buying back their own shares, so each remaining share owns a bigger slice).
Dividends and buybacks
Diluted shares outstanding (annual)
KIRA Β· No open-market insider trades in the last 12 months.
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. βPlanβ marks trades under a pre-arranged Rule 10b5-1 plan.
In plain words: Insiders are the people who run or own a big part of the company. Buying with their own money can signal confidence; selling often has personal reasons, like taxes or diversifying.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Can it carry its debts, and how well does it use its money?
KIRA Β· Precision Optics Corporation, Inc. has $8.5M more cash than debt.
Cash, debt and the ratios that show how comfortably Precision Optics Corporation, Inc. can carry it.
In plain words: What the company owns and what it owes. More cash than debt is a cushion for bad times; a lot of debt leaves less room when business slows down.
Cash vs debt (incl. leases)
| Fiscal year end | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash and short-term investments | $0.6M | $2.9M | $0.4M | $1.8M | $9.8M |
| Debt incl. finance leases | $2.5M | $2.7M | $2.2M | $1.9M | $1.3M |
| Debt / equity | 0.3x | 0.2x | 0.2x | 0.2x | 0.1x |
| Interest coverage | β9.7x | β2.9x | β12.1x | β24.5x | β23.7x |
| Current ratio | 1.4x | 1.9x | 1.5x | 1.6x | 2.3x |
| Quick ratio | 0.8x | 1.3x | 0.9x | 1.1x | 1.8x |
| Total assets | $16.7M | $19.7M | $16.9M | $19.8M | $32.3M |
| Total liabilities | $7.7M | $7.7M | $6.8M | $7.5M | $12.0M |
| Shareholders' equity | $9.0M | $12.0M | $10.1M | $12.3M | $20.3M |
| Net debt (β = net cash) | $1.9M | β$0.2M | $1.8M | $0.2M | β$8.5M |
KIRA Β· Its return on capital was β23.4%: every 100 invested in the business earned about β23 in a year.
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
In plain words: How much profit the business makes on the money put into it. A higher percentage means each dollar invested works harder.
Return on capital, equity and assets (annual)
KIRA Β· Precision Optics Corporation, Inc. passes 5 of 9 financial health tests (Piotroski F-score).
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
In plain words: Nine yes/no tests of financial health, one point each. A green tick is a pass: 7 to 9 points is solid, 0 to 3 is weak.
| Test | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 4 / 8 | 2 / 8 | 3 / 8 | 5 / 8 | 1 / 9 | 6 / 9 | 3 / 9 | 3 / 9 | 5 / 9 |
| Accruals ratio | β18.8% | β21.0% | 8.3% | β12.0% | β2.4% | 0.0% | β0.3% | β1.5% | β13.0% | β8.0% |
| Altman Z'' | β82.39 | β57.81 | β17.13 | β22.99 | β21.88 | β8.02 | β5.01 | β8.55 | β8.27 | β2.77 |
Every number, year by year.
Amounts in USD. Hover a ratioβs name for its definition.
In plain words: Every number we have, year by year. Download it as a spreadsheet if you want to dig deeper.
| Fiscal year | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $3.2M | $4.0M | $6.8M | $9.9M | $10.7M | $15.7M | $21.0M | $19.1M | $19.1M | $31.5M |
| Gross profit | $0.8M | $1.5M | $2.1M | $3.4M | $3.4M | $4.9M | $7.7M | $5.8M | $3.4M | $5.4M |
| Research and development | $0.5M | $0.5M | $0.5M | $0.9M | $0.6M | $0.7M | $1.0M | $1.0M | $1.2M | $1.0M |
| Operating income | β$1.0M | β$0.3M | β$0.6M | β$1.4M | β$0.9M | β$1.5M | β$0.6M | β$2.7M | β$5.6M | β$3.5M |
| Interest expense | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.2M | $0.2M | $0.2M | $0.2M | $0.1M |
| Pretax income | β$1.0M | β$0.4M | β$0.6M | β$1.4M | β$0.1M | β$0.9M | β$0.1M | β$2.9M | β$5.8M | β$3.6M |
| Income tax | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Net income | β$1.0M | β$0.4M | β$0.6M | β$1.4M | β$0.1M | β$0.9M | β$0.1M | β$3.0M | β$5.8M | β$3.6M |
| Net income to common | β | β | β | β | β$0.1M | β$0.9M | β$0.1M | β$3.0M | β$5.8M | β$3.6M |
| Diluted EPS | β$0.12 | β$0.04 | β$0.05 | β$0.11 | β$0.01 | β$0.18 | β$0.03 | β$0.49 | β$0.85 | β$0.43 |
| Diluted shares | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B |
| Cash flow | ||||||||||
| Cash from operations | β$0.7M | $0.1M | β$1.0M | β$0.6M | $0.0M | β$0.9M | β$0.1M | β$2.7M | β$3.4M | β$1.6M |
| Capital expenditure | $0.0M | $0.0M | $0.1M | $0.1M | $0.1M | $0.1M | $0.0M | $0.3M | $0.2M | $0.4M |
| Free cash flow | β$0.7M | $0.1M | β$1.2M | β$0.7M | β$0.0M | β$1.0M | β$0.1M | β$3.0M | β$3.6M | β$2.0M |
| Depreciation and amortization | $0.0M | $0.0M | $0.0M | $0.1M | $0.1M | $0.2M | $0.2M | $0.2M | $0.2M | $0.3M |
| Stock-based compensation | $0.2M | $0.1M | $0.3M | $0.5M | $0.7M | $0.9M | $0.9M | $1.0M | $1.6M | $1.1M |
| Acquisitions | β | β | $0.0M | $1.4M | $0.2M | β | β | β | β | β |
| Balance sheet | ||||||||||
| Cash and short-term investments | $0.1M | $0.4M | $2.3M | $1.1M | $0.9M | $0.6M | $2.9M | $0.4M | $1.8M | $9.8M |
| Total debt | β | β | β | β | $0.0M | $2.4M | $2.7M | $2.2M | $1.9M | $1.3M |
| Finance lease liabilities | β | β | β | β | β | $0.2M | β | β | β | β |
| Current assets | $1.7M | $2.4M | $6.4M | $4.9M | $4.8M | $6.5M | $9.9M | $7.1M | $10.1M | $20.1M |
| Current liabilities | $1.2M | $1.9M | $3.6M | $3.1M | $2.5M | $4.6M | $5.3M | $4.9M | $6.2M | $8.8M |
| Inventory | $1.1M | $1.1M | $1.7M | $2.2M | $1.9M | $3.0M | $2.8M | $2.9M | $3.6M | $3.8M |
| Property and equipment, net | $0.1M | $0.0M | $0.4M | $0.5M | $0.6M | $0.6M | $0.4M | $0.5M | $0.5M | $0.9M |
| Goodwill | β | $0.0M | $0.7M | $0.7M | $0.7M | $8.8M | $8.8M | $8.8M | $8.8M | $8.8M |
| Intangible assets | $0.0M | $0.0M | $0.1M | $0.1M | $0.1M | $0.2M | $0.3M | $0.3M | $0.2M | $0.2M |
| Total assets | $1.8M | $2.5M | $7.5M | $6.4M | $6.3M | $16.7M | $19.7M | $16.9M | $19.8M | $32.3M |
| Total liabilities | $1.2M | $1.9M | $4.1M | $3.6M | $2.8M | $7.7M | $7.7M | $6.8M | $7.5M | $12.0M |
| Shareholders' equity | $0.6M | $0.6M | $3.4M | $2.8M | $3.4M | $9.0M | $12.0M | $10.1M | $12.3M | $20.3M |
| Margins | ||||||||||
| Gross margin | 24.5% | 36.7% | 31.2% | 33.9% | 32.2% | 31.4% | 36.8% | 30.3% | 17.8% | 17.2% |
| Operating margin | β31.8% | β8.6% | β9.0% | β14.3% | β8.5% | β9.7% | β3.0% | β14.3% | β29.1% | β11.1% |
| EBITDA margin | β30.7% | β8.0% | β8.4% | β13.2% | β7.1% | β8.4% | β2.0% | β13.1% | β28.0% | β10.2% |
| Net margin | β31.9% | β8.7% | β9.0% | β14.4% | β1.0% | β5.9% | β0.7% | β15.4% | β30.3% | β11.5% |
| FCF margin | β22.0% | 2.4% | β17.2% | β7.2% | β0.3% | β6.7% | β0.5% | β15.5% | β19.0% | β6.3% |
| Returns | ||||||||||
| Return on capital | β | β | β | β | β27.8% | β11.2% | β4.3% | β18.1% | β35.3% | β23.4% |
| Return on capital employed | β172.3% | β60.2% | β15.8% | β44.4% | β24.1% | β12.5% | β4.4% | β22.7% | β40.7% | β14.9% |
| Return on equity | β180.2% | β62.6% | β31.2% | β46.4% | β3.3% | β15.0% | β1.4% | β26.7% | β51.8% | β22.3% |
| Return on assets | β55.9% | β16.3% | β12.3% | β20.6% | β1.6% | β8.1% | β0.8% | β16.1% | β31.5% | β13.9% |
| Return on tangible equity | β190.5% | β68.0% | β23.3% | β71.7% | β4.0% | β | β4.9% | β308.4% | β180.5% | β32.1% |
| Growth | ||||||||||
| Revenue growth | β | 28.0% | 68.5% | 45.8% | 7.6% | 46.9% | 34.2% | β9.2% | β0.1% | 65.2% |
| FCF growth | β | β | β1,316.7% | β | β | β | β | β | β | β |
| Share count change | β | 17.8% | 16.9% | 13.2% | 2.2% | β60.1% | 7.0% | 7.1% | 11.9% | 25.6% |
| Financial health | ||||||||||
| Debt / equity | β | β | β | β | 0.0x | 0.3x | 0.2x | 0.2x | 0.2x | 0.1x |
| Interest coverage | β323.4x | β183.5x | β437.5x | β1,423.0x | β170.9x | β9.7x | β2.9x | β12.1x | β24.5x | β23.7x |
| Current ratio | 1.4x | 1.2x | 1.8x | 1.6x | 1.9x | 1.4x | 1.9x | 1.5x | 1.6x | 2.3x |
| Quick ratio | 0.5x | 0.7x | 1.3x | 0.9x | 1.2x | 0.8x | 1.3x | 0.9x | 1.1x | 1.8x |
| Capital allocation | ||||||||||
| Capex / revenue | 0.9% | 0.1% | 2.1% | 1.2% | 0.7% | 0.7% | 0.1% | 1.4% | 1.2% | 1.4% |
| Stock comp / revenue | 6.4% | 1.3% | 3.9% | 5.1% | 6.9% | 5.8% | 4.4% | 5.0% | 8.4% | 3.6% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 4.0 | 2.0 | 3.0 | 5.0 | 1.0 | 6.0 | 3.0 | 3.0 | 5.0 |
| Altman Z'' | β82.4 | β57.8 | β17.1 | β23.0 | β21.9 | β8.0 | β5.0 | β8.5 | β8.3 | β2.8 |
| Accruals ratio | β18.8% | β21.0% | 8.3% | β12.0% | β2.4% | 0.0% | β0.3% | β1.5% | β13.0% | β8.0% |
Source: SEC EDGAR XBRL filings (CIK 0000867840). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.
